Teleflex Incorporated (TFX) To Go Ex-Dividend on November 14th

Teleflex Incorporated (NYSE:TFX) declared a quarterly dividend on Thursday, November 6th. Investors of record on Friday, November 14th will be paid a dividend of 0.34 per share by the medical technology company on Monday, December 15th. This represents a c) annualized dividend and a dividend yield of 1.2%. The ex-dividend date of this dividend is Friday, November 14th.

Teleflex has a payout ratio of 9.7% indicating that its dividend is sufficiently covered by earnings. Analysts expect Teleflex to earn $15.18 per share next year, which means the company should continue to be able to cover its $1.36 annual dividend with an expected future payout ratio of 9.0%.

Teleflex Price Performance

Teleflex stock traded up $1.74 during trading on Wednesday, reaching $114.00. The company had a trading volume of 81,843 shares, compared to its average volume of 740,140. The firm’s 50-day simple moving average is $124.99 and its 200 day simple moving average is $122.64. The firm has a market capitalization of $5.04 billion, a PE ratio of 26.82, a price-to-earnings-growth ratio of 1.79 and a beta of 1.05. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.44 and a current ratio of 2.41. Teleflex has a 1-year low of $102.58 and a 1-year high of $197.43.

Teleflex (NYSE:TFX) last posted its quarterly earnings results on Thursday, November 6th. The medical technology company reported $3.67 EPS for the quarter, topping the consensus estimate of $3.38 by $0.29. The business had revenue of $892.90 million during the quarter, compared to the consensus estimate of $892.79 million. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. The company’s quarterly revenue was up 19.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $3.49 earnings per share. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. As a group, equities research analysts anticipate that Teleflex will post 13.98 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Teleflex

Hedge funds have recently made changes to their positions in the company. Thurston Springer Miller Herd & Titak Inc. increased its stake in shares of Teleflex by 242.9% during the 2nd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 216 shares of the medical technology company’s stock worth $26,000 after purchasing an additional 153 shares during the last quarter. MassMutual Private Wealth & Trust FSB increased its holdings in shares of Teleflex by 57.9% during the 3rd quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company’s stock valued at $26,000 after acquiring an additional 77 shares during the last quarter. Banque Cantonale Vaudoise bought a new position in shares of Teleflex in the 1st quarter valued at approximately $27,000. Costello Asset Management INC acquired a new stake in Teleflex in the 1st quarter worth approximately $28,000. Finally, Brooklyn Investment Group grew its holdings in Teleflex by 258.6% during the first quarter. Brooklyn Investment Group now owns 208 shares of the medical technology company’s stock valued at $29,000 after purchasing an additional 150 shares during the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.